Atrial fibrillation causes thrombosis through three simultaneous problems: blood pools and stagnates in the upper left chamber of the heart, the inner lining of that chamber deteriorates, and the blood itself becomes more prone to clotting. These three factors work together to create ideal conditions for a blood clot to form, most often in a small pouch called the left atrial appendage. If that clot breaks free, it can travel to the brain and cause a stroke.
Why Blood Stagnates During AFib
In a normal heartbeat, the atria contract in a coordinated squeeze that pushes blood efficiently into the ventricles below. During atrial fibrillation, that organized contraction is replaced by rapid, chaotic quivering. The atria never fully empty, and blood lingers instead of moving through.
This stagnation is visible on imaging as “spontaneous echo contrast,” sometimes called smoke, a swirling haze of slow-moving blood. Doctors can measure how fast blood flows through the left atrial appendage using echocardiography. In healthy people, flow velocity in this area is typically 50 to 60 centimeters per second. In AFib patients at high risk for clots, that speed can drop well below 20 cm/s. Research from the LAT study found that patients with flow velocities under 20 cm/s had a stroke or systemic embolism rate of 10.8%, compared to just 2.1% in those with faster flow. Clots that form when flow is this sluggish also tend to resist blood-thinning medication.
Where Clots Form: The Left Atrial Appendage
The left atrial appendage is a small, finger-like pouch extending from the left atrium. It has an irregular, trabeculated interior full of ridges and pockets. During AFib, when the atrium stops contracting properly, this complex shape becomes a trap for stagnant blood. The vast majority of clots in non-valvular AFib originate here.
The shape of this appendage varies from person to person, and that shape matters. Researchers have classified it into four main types: chicken wing, cauliflower, cactus, and windsock. The chicken wing shape, which bends sharply and allows blood to move through more easily, carries the lowest risk. People with a cauliflower-shaped appendage, which is rounder and more complex, have roughly 46% more stroke events than those with a chicken wing shape. The windsock shape carries about 31% more risk. In one meta-analysis, strokes were reported in 39.4% of patients with cauliflower morphology, compared to 18.6% with windsock morphology.
How the Atrial Wall Becomes Prothrombotic
AFib doesn’t just slow blood flow. It physically damages the inner lining of the atrium over time. The endocardium, the thin layer of cells lining the heart’s interior, gradually breaks down. This process, called endocardial denudation, exposes the underlying tissue, including collagen fibers that directly activate the clotting cascade when they come into contact with blood.
Healthy endocardium actively prevents clotting by releasing substances that keep blood flowing smoothly. When that barrier is damaged, two things happen simultaneously: the protective anti-clotting signals disappear, and the exposed collagen triggers clotting factor activation. Inflammatory molecules can also penetrate through the damaged lining and promote fibrosis, or scarring, in the atrial tissue beneath. This creates a self-reinforcing cycle where inflammation leads to more structural damage, which creates more surface area for clots to form.
The atrium itself also physically enlarges during prolonged AFib. This progressive dilation stretches the chamber walls and further disrupts normal blood flow patterns, adding to stagnation.
Changes in the Blood Itself
Beyond what happens in the heart’s structure, AFib alters the composition of the blood flowing through it. People with AFib show significantly elevated levels of several clotting-related markers compared to people without the condition. D-dimer, a protein fragment produced when clots break down (and a sign of active clot formation), is markedly elevated. So is fibrinogen, a protein essential for clot construction, and von Willebrand factor, which helps platelets stick to damaged vessel walls.
Platelets themselves become more activated during AFib. Markers of platelet activation like P-selectin and platelet factor 4 are significantly higher in AFib patients. This means the blood isn’t just sitting still in the atrium. It’s actively primed to clot. This systemic hypercoagulability may explain why even brief episodes of AFib can carry real thrombotic risk, and why clots sometimes form even in parts of the cardiovascular system outside the left atrium.
How a Clot Becomes a Stroke
Once a thrombus forms in the left atrium, it sits in the direct path of oxygenated blood leaving the heart for the rest of the body. If the clot, or a piece of it, detaches, it enters the left ventricle and is pumped out through the aorta. From there, it travels upward through the carotid arteries and into the brain’s blood supply, where it can lodge in a cerebral artery and block blood flow.
Even small clots can cause significant damage depending on where they land. A tiny fragment that blocks a vessel supplying a critical area of the brain can produce lasting cognitive disability. This is why AFib-related strokes tend to be more severe than strokes caused by other mechanisms. The clots originating in the heart are often larger than those that form locally in narrowed brain arteries.
The 48-Hour Rule and Its Limits
Clinical guidelines have traditionally treated AFib episodes lasting less than 48 hours as low risk for clot formation, allowing doctors to restore normal rhythm without weeks of blood-thinning medication first. However, recent evidence challenges this threshold. In a study of patients with newly diagnosed AFib, clots were found in 21% of those who presented within 48 hours of symptom onset, compared to 33% who presented later. That difference was not statistically significant.
Neither symptom duration nor standard stroke risk scores reliably predicted which patients had clots. The strongest predictors were age 65 or older, the presence of acute heart failure, and a history of coronary or peripheral artery disease. This suggests that the prothrombotic changes in AFib, particularly the blood composition changes and endocardial damage, may already be well-established by the time symptoms begin, making even short episodes more dangerous than previously assumed.
Putting the Mechanisms Together
What makes AFib such an effective driver of thrombosis is that it satisfies all three conditions for clot formation simultaneously: stagnant flow, a damaged vessel surface, and blood that clots too readily. These three elements, first described by the pathologist Rudolf Virchow in the 19th century, rarely converge this completely in other conditions. Each one alone might not produce a clot. Together, they make clot formation in the left atrium almost inevitable without treatment, particularly in patients with additional risk factors like age, heart failure, or vascular disease.